Autek China Inc (300595) - Total Liabilities

Latest as of September 2025: CN¥994.27 Million CNY ≈ $145.49 Million USD

Based on the latest financial reports, Autek China Inc (300595) has total liabilities worth CN¥994.27 Million CNY (≈ $145.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300595 cash generation efficiency to assess how effectively this company generates cash.

Autek China Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Autek China Inc's total liabilities have evolved over time, based on quarterly financial data. Check 300595 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Autek China Inc Competitors by Total Liabilities

The table below lists competitors of Autek China Inc ranked by their total liabilities.

Company Country Total Liabilities
Galapagos NV ADR
NASDAQ:GLPG
USA $170.58 Million
Tabcorp Holdings Ltd
AU:TAH
Australia AU$1.87 Billion
GeneDx Holdings Corp.
NASDAQ:WGS
USA $201.64 Million
Intapp Inc
NASDAQ:INTA
USA $384.93 Million
Diamondrock Hospitality Company Common Stock
NYSE:DRH
USA $1.57 Billion
Beach Energy Ltd
AU:BPT
Australia AU$2.25 Billion
Zhongli Science and Technology Group Co Ltd
SHE:002309
China CN¥3.70 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Autek China Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Autek China Inc (300595) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Autek China Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Autek China Inc (2012–2024)

The table below shows the annual total liabilities of Autek China Inc from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥887.24 Million
≈ $129.83 Million
+9.83%
2023-12-31 CN¥807.85 Million
≈ $118.21 Million
+54.45%
2022-12-31 CN¥523.05 Million
≈ $76.54 Million
+19.87%
2021-12-31 CN¥436.35 Million
≈ $63.85 Million
+96.79%
2020-12-31 CN¥221.74 Million
≈ $32.45 Million
+31.85%
2019-12-31 CN¥168.17 Million
≈ $24.61 Million
+15.76%
2018-12-31 CN¥145.28 Million
≈ $21.26 Million
+31.80%
2017-12-31 CN¥110.23 Million
≈ $16.13 Million
+165.23%
2016-12-31 CN¥41.56 Million
≈ $6.08 Million
-3.95%
2015-12-31 CN¥43.27 Million
≈ $6.33 Million
+138.95%
2014-12-31 CN¥18.11 Million
≈ $2.65 Million
+6.17%
2013-12-31 CN¥17.06 Million
≈ $2.50 Million
+56.76%
2012-12-31 CN¥10.88 Million
≈ $1.59 Million
--

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.89 Billion
CN¥12.91 Billion CNY
Market Cap Rank
#6483 Global
#1467 in China
Share Price
CN¥14.42
Change (1 day)
+0.91%
52-Week Range
CN¥13.78 - CN¥19.38
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic … Read more